SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $72.96 | 52-week high | $92.60 |
| Prev. close | $73.70 | 52-week low | $72.44 |
| Day low | $72.81 | Volume | 10,312,900 |
| Day high | $74.22 | Avg. volume | 7,817,006 |
| 50-day MA | $79.99 | Dividend yield | N/A |
| 200-day MA | $82.28 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 5.65B |
| Net Asset Value (NAV) | $73.68 |
| Options? | Yes |
| Total Holdings | 139 |
XBI Top Holdings
| Symbol | Company | % of Total |
| APLS | APELLIS PHARMACEUTICALS INC | 1.49% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.33% |
| AMGN | AMGEN INC | 1.33% |
| ALKS | ALKERMES PLC | 1.33% |
| IONS | IONIS PHARMACEUTICALS INC | 1.31% |
| ABBV | ABBVIE INC | 1.31% |
| HALO | HALOZYME THERAPEUTICS INC | 1.31% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.31% |
| SGEN | SEAGEN INC | 1.29% |
| RXRX | RECURSION PHARMACEUTICALS A | 1.28% |
XBI Price Returns
| 1-mo | -6.25% |
| 3-mo | -14.29% |
| 6-mo | -2.65% |
| 1-year | -4.81% |
| 3-year | -33.06% |
| 5-year | -24.29% |
| YTD | -12.09% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
| 2019 | 32.56% |
| 2018 | -15.28% |